Drugs / IRI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04259944 | Jun 2020 → Jul 2024 | colon carcinoma | IFOM ETS - The AIRC Institute of Molecular Oncology | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IRI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04259944 ↗ |
| Route | Intravenous | “IRI, 180 mg/m2 administered as iv infusion” NCT04259944 ↗ |